AGMB
AgomAb Therapeutics NV
8.60$
-1.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | – | – | – | |
| – | – | – | – | |
| – | – | – | – | |
| – | +35.5% | +49.4% | +24.3% | |
| – | +33.6% | +63.8% | +28.0% | |
| – | +37.8% | +54.0% | +23.4% | |
| – | – | – | – | |
| – | -31.1% | +116.1% | -10.4% | |
| – | – | – | – | |
| – | – | – | +0.0% | |
| – | – | – | – | |
| – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.